Company: OXBRW
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001493152-25-021063
Chunk: 105

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 105
---
 principal executive officer and principal financial
officer to allow timely decisions regarding required disclosures.

Based
on that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered
by this Report on Form 10-Q, our disclosure controls and procedures were effective.

It
should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance
that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions
about the likelihood of future events.

Changes
in Internal Control Over Financial Reporting

There
have been no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2025 that
have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART
II – OTHER INFORMATION

Item
1. Legal Proceedings

We
are not currently involved in any litigation or arbitration. We anticipate that, similar to the rest of the insurance and reinsurance
industry, we will be subject to litigation and arbitration in the ordinary course of business.

Item
1A. Risk Factors

There
have been no material changes to our risk factors during the nine-months ended September 30, 2025.

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds

On
September 30, 2022, we entered into an “at the market” (ATM) sales agreement with Maxim Group LLC as our sales agent, under
which we may offer and sell from time to time up to $6.3 million of ordinary shares in negotiated transactions or transactions that are
deemed to be an ATM offering. On July 9, 2025, this sales agreement was replaced by a new sales agreement with our sales agent, under
which we may offer and sell from time to time up to $5 million of ordinary shares in negotiated transactions or transactions that are
deemed to be an ATM offering.

During
the period ended September 30, 2025, we have sold 287,915 ordinary shares under the ATM program for gross proceeds of $900,531 at an
average price of $3.13 per share. After deducting commissions related to the ATM offering of $27,016, the net proceeds we received from
the transactions were $873,515. The proceeds from the ATM sales are being used for general corporate purposes.

Item
3.